Cargando…
Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies
Several studies have inspected the relationship between rs735482 polymorphism and the risk of some human cancers, but the findings remain controversial. We designed this meta-analysis to validate the association between rs735482 polymorphism and cancer risk. All articles were published before Septem...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333535/ https://www.ncbi.nlm.nih.gov/pubmed/35905230 http://dx.doi.org/10.1097/MD.0000000000029318 |
_version_ | 1784758899224608768 |
---|---|
author | Xue, Shilin Shen, Wenya Cai, Jianning Jia, Jinhai Zhao, Dan Zhang, Shan Zhao, Xiujun Ma, Ning Wang, Wenjuan Wang, Bingshuang Zhang, Xiaolin Liu, Xuehui |
author_facet | Xue, Shilin Shen, Wenya Cai, Jianning Jia, Jinhai Zhao, Dan Zhang, Shan Zhao, Xiujun Ma, Ning Wang, Wenjuan Wang, Bingshuang Zhang, Xiaolin Liu, Xuehui |
author_sort | Xue, Shilin |
collection | PubMed |
description | Several studies have inspected the relationship between rs735482 polymorphism and the risk of some human cancers, but the findings remain controversial. We designed this meta-analysis to validate the association between rs735482 polymorphism and cancer risk. All articles were published before September 1, 2018 and searched in Pubmed, Embase, Web of Science, China National Knowledge Infrastructure, WangFang, and Chinese BioMedical databases, STATA 12.0 software was used for statistical analysis, which provides reasonable data and technical support for this article. A total of 10 studies were included in the meta-analysis, including 2652 cancer cases and 3536 rs735482 polymorphic controls. Data were directly extracted from these studies and odds ratios with 95% confidence intervals were computed to estimate the strength of the association. By pooling all eligible studies, the rs735482 polymorphism showed no significant association with susceptibility of several cancers in all the five genetic models (the allelic model: OR = 1.019, 95% CI: 0.916–1.134, P = .731). In addition, another adjusted OR data showed a significant increased risk between the rs735482 and susceptibility of several cancers (the codominant model BB vs AA: OR = 1.353, 95% CI: 1.033–1.774, P = .028) and the stratification analysis by ethnicity indicated the rs735482 is associated with an increased risk of cancer in Chinese group (BB vs AA, OR = 1.391, 95% CI = 1.054–1.837, P = .020; AB+BB vs AA OR = 1.253, 95% CI = 1.011–1.551, P = .039). However, the ERCC1 rs735482 is associated with a decreased risk of cancer in Italian group (AB vs AA, OR = 0.600, 95% CI = 0.402–0.859, P = .012; AB + BB vs AA, OR = 0.620, 95% CI = 0.424–0.908, P = .014). The results of this meta-analysis do not support the association between rs735482 polymorphism and cancer risk. But stratified analysis showed that rs735482 significantly increased the risk of cancer in Chinese while decreased the risk of cancer in Italian. Because of the limited number of samples, larger and well-designed researches are needed to estimate this association in detail. |
format | Online Article Text |
id | pubmed-9333535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-93335352022-08-03 Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies Xue, Shilin Shen, Wenya Cai, Jianning Jia, Jinhai Zhao, Dan Zhang, Shan Zhao, Xiujun Ma, Ning Wang, Wenjuan Wang, Bingshuang Zhang, Xiaolin Liu, Xuehui Medicine (Baltimore) Research Article Several studies have inspected the relationship between rs735482 polymorphism and the risk of some human cancers, but the findings remain controversial. We designed this meta-analysis to validate the association between rs735482 polymorphism and cancer risk. All articles were published before September 1, 2018 and searched in Pubmed, Embase, Web of Science, China National Knowledge Infrastructure, WangFang, and Chinese BioMedical databases, STATA 12.0 software was used for statistical analysis, which provides reasonable data and technical support for this article. A total of 10 studies were included in the meta-analysis, including 2652 cancer cases and 3536 rs735482 polymorphic controls. Data were directly extracted from these studies and odds ratios with 95% confidence intervals were computed to estimate the strength of the association. By pooling all eligible studies, the rs735482 polymorphism showed no significant association with susceptibility of several cancers in all the five genetic models (the allelic model: OR = 1.019, 95% CI: 0.916–1.134, P = .731). In addition, another adjusted OR data showed a significant increased risk between the rs735482 and susceptibility of several cancers (the codominant model BB vs AA: OR = 1.353, 95% CI: 1.033–1.774, P = .028) and the stratification analysis by ethnicity indicated the rs735482 is associated with an increased risk of cancer in Chinese group (BB vs AA, OR = 1.391, 95% CI = 1.054–1.837, P = .020; AB+BB vs AA OR = 1.253, 95% CI = 1.011–1.551, P = .039). However, the ERCC1 rs735482 is associated with a decreased risk of cancer in Italian group (AB vs AA, OR = 0.600, 95% CI = 0.402–0.859, P = .012; AB + BB vs AA, OR = 0.620, 95% CI = 0.424–0.908, P = .014). The results of this meta-analysis do not support the association between rs735482 polymorphism and cancer risk. But stratified analysis showed that rs735482 significantly increased the risk of cancer in Chinese while decreased the risk of cancer in Italian. Because of the limited number of samples, larger and well-designed researches are needed to estimate this association in detail. Lippincott Williams & Wilkins 2022-07-29 /pmc/articles/PMC9333535/ /pubmed/35905230 http://dx.doi.org/10.1097/MD.0000000000029318 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Xue, Shilin Shen, Wenya Cai, Jianning Jia, Jinhai Zhao, Dan Zhang, Shan Zhao, Xiujun Ma, Ning Wang, Wenjuan Wang, Bingshuang Zhang, Xiaolin Liu, Xuehui Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies |
title | Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies |
title_full | Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies |
title_fullStr | Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies |
title_full_unstemmed | Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies |
title_short | Association between rs735482 polymorphism and risk of cancer: A meta-analysis of 10 case–control studies |
title_sort | association between rs735482 polymorphism and risk of cancer: a meta-analysis of 10 case–control studies |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9333535/ https://www.ncbi.nlm.nih.gov/pubmed/35905230 http://dx.doi.org/10.1097/MD.0000000000029318 |
work_keys_str_mv | AT xueshilin associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies AT shenwenya associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies AT caijianning associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies AT jiajinhai associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies AT zhaodan associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies AT zhangshan associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies AT zhaoxiujun associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies AT maning associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies AT wangwenjuan associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies AT wangbingshuang associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies AT zhangxiaolin associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies AT liuxuehui associationbetweenrs735482polymorphismandriskofcancerametaanalysisof10casecontrolstudies |